Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - TOTAL CURRENT LIABILITIES
Total Current Liabilities CRVS - Corvus Pharmaceuticals, Inc.
6.87 M
LAST VALUE
-25.25%
2 YEAR CAGR
-2.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR